Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks

被引:34
作者
Banerjee, Dibyendu [2 ,3 ]
Lelandais, Gaelle [1 ,4 ]
Shukla, Sudhanshu [3 ]
Mukhopadhyay, Gauranga [2 ]
Jacq, Claude [1 ]
Devaux, Frederic [1 ]
Prasad, Rajendra [3 ]
机构
[1] CNRS, Genet Mol Lab, Ecole Normale Super, UMR 8541, F-75005 Paris, France
[2] JNU, Special Ctr Mol Med, New Delhi, India
[3] JNU, Sch Life Sci, New Delhi, India
[4] Univ Paris 07, INSERM, Equipe Bioinformat Genom & Mol, U726, F-75005 Paris, France
关键词
D O I
10.1128/EC.00256-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Steroids are known to induce pleiotropic drug resistance states in hemiascomycetes, with tremendous potential consequences for human fungal infections. Our analysis of gene expression in Saccharomyces cerevisiae and Candida albicans cells subjected to three different concentrations of progesterone revealed that their pleiotropic drug resistance ( PDR) networks were strikingly sensitive to steroids. In S. cerevisiae, 20 of the Pdr1p/Pdr3p target genes, including PDR3 itself, were rapidly induced by progesterone, which mimics the effects of PDR1 gain-of-function alleles. This unique property allowed us to decipher the respective roles of Pdr1p and Pdr3p in PDR induction and to define functional modules among their target genes. Although the expression profiles of the major PDR transporters encoding genes ScPDR5 and CaCDR1 were similar, the S. cerevisiae global PDR response to progesterone was only partly conserved in C. albicans. In particular, the role of Tac1p, the main C. albicans PDR regulator, in the progesterone response was apparently restricted to five genes. These results suggest that the C. albicans and S. cerevisiae PDR networks, although sharing a conserved core regarding the regulation of membrane properties, have different structures and properties. Additionally, our data indicate that other as yet undiscovered regulators may second Tac1p in the C. albicans drug response.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 39 条
[31]   Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans [J].
Liu, TT ;
Lee, REB ;
Barker, KS ;
Lee, RE ;
Wei, L ;
Homayouni, R ;
Rogers, PD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2226-2236
[32]   CANDIDA-ALBICANS ESTROGEN-BINDING PROTEIN GENE ENCODES AN OXIDOREDUCTASE THAT IS INHIBITED BY ESTRADIOL [J].
MADANI, ND ;
MALLOY, PJ ;
RODRIGUEZPOMBO, P ;
KRISHNAN, AV ;
FELDMAN, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (03) :922-926
[33]   CLONING AND EXPRESSION OF THE GENE FROM CANDIDA-ALBICANS THAT ENCODES A HIGH-AFFINITY CORTICOSTEROID-BINDING PROTEIN [J].
MALLOY, PJ ;
ZHAO, X ;
MADANI, ND ;
FELDMAN, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1902-1906
[34]   Transcriptional control of multidrug resistance in the yeast Saccharomyces [J].
Moye-Rowley, WS .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 73, 2003, 73 :251-279
[35]   Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans [J].
Mukhopadhyay, K ;
Prasad, T ;
Saini, P ;
Pucadyil, TJ ;
Chattopadhyay, A ;
Prasad, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) :1778-1787
[36]  
Pasrija R, 2005, BIOCHEM SOC T, V33, P1219, DOI 10.1042/BST20051219
[37]   Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism [J].
Silver, PM ;
Oliver, BG ;
White, TC .
EUKARYOTIC CELL, 2004, 3 (06) :1391-1397
[38]   Significance analysis of microarrays applied to the ionizing radiation response [J].
Tusher, VG ;
Tibshirani, R ;
Chu, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5116-5121
[39]   Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus [J].
White, TC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1482-1487